about
Teratogenic potential of antiepileptic drugs in the zebrafish modelPain management strategies for neuropathic pain in Fabry disease--a systematic reviewOptogenetic delay of status epilepticus onset in an in vivo rodent epilepsy modelImpact of early life exposure to antiepileptic drugs on neurobehavioral outcomes based on laboratory animal and clinical research.Italian guidelines for primary headaches: 2012 revised versionBicuspid aortic valve and severe aortic stenosis in a newborn exposed to carbamazapine during pregnancy.Brief report novel mechanism for valproate-induced teratogenicity.Developmental effects of antiepileptic drugs and the need for improved regulations.Medical and psychological risks and consequences of long-term opioid therapy in women.Neurological teratogenic effects of antiepileptic drugs during pregnancy.Review about gabapentin misuse, interactions, contraindications and side effects.Facial Dysmorphism: An Unreported Teratogenicity with LevetiracetamTreating epilepsy in pregnant women.Pharmacokinetic and pharmacodynamic interactions between antiepileptics and antidepressants.Foetal safety of old and new antiepileptic drugs.Teratogenic Effects of Topiramate in a Zebrafish Model.Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay.Antiepileptic drugs (AEDs) during pregnancy and risk of congenital jaw and oral malformation.Influencing clinical practice regarding the use of antiepileptic medications during pregnancy: modeling the potential impact on the prevalences of spina bifida and cleft palate in the United States.Trigeminal Neuralgia in Pregnancy: A Management Challenge.The neurotoxic effects of prenatal gabapentin and oxcarbazepine exposure on newborn rats.Newer anticonvulsants: lamotrigine, topiramate and gabapentin.Development of EpiRisk: An online clinical tool for estimating the risk of major congenital malformations in pregnant women treated for epilepsy.Antiepileptic drugs and pregnancy outcomes.
P2860
Q21284780-D3CA3B61-3B96-4429-8814-FE9221A42D35Q26766561-12A30251-30A8-4FF7-823D-D228205ED947Q27323875-CB0DAEBE-4444-4DE6-938E-48444C5AEEDCQ30443028-E13AF1CE-CCA3-463F-A592-3AE43E49D981Q30466790-70EDABF2-EC12-4CE7-9716-7A219CB404F7Q34843195-43407EFD-3EBD-462B-A17E-8DDDB65F0DEAQ35414137-052F6F36-7CA9-4699-B30D-915828EF3603Q36521267-679915ED-DF3A-4A90-B935-F99BB2EFCA63Q36709787-D2183700-71D9-413F-8337-9F13E0569EA6Q37287941-D3BAD76E-F33C-47DB-A7C6-D24F937E2EB1Q37641479-7A8C7FCC-0486-44BD-A039-418384768979Q37663687-E0A2F512-F3F8-4BC0-9BFE-1B23EBDB7D63Q38194574-AC521BE0-9469-425E-A0A8-2F9BDD373A8CQ38246706-BCF0B8FF-4754-4FCE-B232-A9BE60EA385EQ38578361-BEF60E40-5128-4DAC-8DD5-D2C57BBF5F06Q38637207-5A3332CB-BDFC-4BB8-8720-8205807AD6DDQ42701756-D5CEE5A2-A186-45EB-B7DA-1D280A6B3B22Q44972044-B3C5CD01-E8BE-4099-8FDE-FC3D8DA086FCQ45975878-F9C1BEEA-21AC-4E5D-84B1-001CB174BAB4Q47289917-8502A7C8-FB63-4160-AADB-6DB37940CC8DQ47633139-E1228AB4-DE68-4BEE-BE3A-A22A3E7411A1Q50799679-8A47A5A3-CDB4-4D4B-B3F3-D5C6BBEB5D09Q55313289-C28B78B7-213E-4075-813B-E5686FF1C17DQ55716842-9485AA6E-97D6-49F5-8A71-31B1DE5FEB12
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Teratogenic effects of antiepileptic drugs
@ast
Teratogenic effects of antiepileptic drugs
@en
Teratogenic effects of antiepileptic drugs
@nl
type
label
Teratogenic effects of antiepileptic drugs
@ast
Teratogenic effects of antiepileptic drugs
@en
Teratogenic effects of antiepileptic drugs
@nl
prefLabel
Teratogenic effects of antiepileptic drugs
@ast
Teratogenic effects of antiepileptic drugs
@en
Teratogenic effects of antiepileptic drugs
@nl
P2860
P50
P356
P1476
Teratogenic effects of antiepileptic drugs
@en
P2093
Denise S Hill
P2860
P304
P356
10.1586/ERN.10.57
P577
2010-06-01T00:00:00Z